BLRX ▼ -19.9% - BioLineRx Ltd. $BLRX BLRX - BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement BioLineRx shares fell 19.9% today following the company's announcement of a $3.75 million registered direct offering and concurrent private placement. Dilutive equity offerings typically pressure stock prices as they increase the number of shares outstanding and can signal financial constraints, which explains the significant intraday decline. 28-AUG-2026 08:00 AM ET